Eliem Therapeutics, Inc.
NASDAQ:ELYM
5.11 (USD) • At close October 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 223.14 | 105.031 | 93.112 | 57.353 | 25.294 | 34.437 | 43.585 | 35.944 | 32.602 | 31.931 | 46.922 | 62.819 | 99.482 | 47.911 | 20.487 | -21.223 |
Short Term Investments
| 0 | 0 | 13.686 | 50.08 | 77.339 | 74.935 | 79.981 | 86.675 | 90.349 | 92.01 | 89.558 | 83.199 | 0 | 0 | 0 | 42.446 |
Cash and Short Term Investments
| 223.14 | 105.031 | 106.798 | 107.433 | 102.633 | 109.372 | 123.566 | 122.619 | 122.951 | 123.941 | 136.48 | 146.018 | 99.482 | 47.911 | 20.487 | 21.223 |
Net Receivables
| 0 | 2.021 | 2.024 | 1.922 | 6.865 | 6.587 | 6.492 | 5.066 | 5.851 | 6.523 | 6.523 | 0 | 2.541 | 2.535 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 2.478 | 4.117 | -7.208 | -6.492 | 4.931 | 3.172 | 2.219 | -6.523 | 4.621 | 2.322 | 1.483 | 0 | 0 |
Other Current Assets
| 3.16 | 2.171 | 1.433 | 3.079 | 4.746 | 4.215 | 4.335 | 5.486 | 4.274 | 2.819 | 5.249 | 17.235 | 2.78 | 2.091 | 1.511 | 0 |
Total Current Assets
| 225.997 | 108.271 | 110.255 | 112.434 | 114.244 | 109.372 | 134.393 | 133.171 | 133.076 | 133.283 | 148.252 | 158.632 | 104.803 | 52.537 | 21.998 | 21.223 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 0.021 | 0.111 | 0.199 | 0.286 | 0.372 | 0.662 | 0.471 | 0.585 | 0.697 | 0.807 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.961 | 11.701 | 25.911 | 24.919 | 23.619 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| -0 | 0.952 | 0.015 | 0.015 | 1.658 | 12.051 | 0.128 | 0.141 | 4.631 | 2.418 | 0.07 | 0 | 2.824 | 1.149 | 2.633 | -21.223 |
Total Non-Current Assets
| 0.021 | 1.063 | 0.214 | 0.301 | 2.03 | 12.713 | 0.599 | 7.687 | 17.029 | 29.136 | 24.989 | 23.619 | 2.824 | 1.149 | 2.633 | -21.223 |
Total Assets
| 226.018 | 109.334 | 110.469 | 112.735 | 116.274 | 122.085 | 134.992 | 140.858 | 150.105 | 162.419 | 173.241 | 182.251 | 107.627 | 53.686 | 24.631 | 0 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 0.509 | 0.085 | 0.066 | 0.736 | 0.878 | 0.864 | 0.75 | 1.494 | 1.061 | 0.847 | 1.404 | 2.579 | 1.955 | 2.003 | 1.086 | 0 |
Short Term Debt
| 0.2 | 0.225 | 0.668 | 0.802 | 0.97 | 0.928 | 0.3 | 0.704 | 0.878 | 0.918 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| -0.509 | -0.085 | -0.066 | 0 | 0 | 0 | 0 | -0.352 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 3.032 | 2.64 | 2.099 | 1.363 | 1.77 | 3.123 | 5.047 | 4.082 | 5.675 | 5.131 | 4.627 | 3.011 | 3.758 | 2.067 | 1.977 | 0 |
Total Current Liabilities
| 3.741 | 2.95 | 2.833 | 2.901 | 3.618 | 4.915 | 6.097 | 6.28 | 7.614 | 6.896 | 6.031 | 5.59 | 5.713 | 4.07 | 3.063 | 0 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 0 | 0 | 0.03 | 0.116 | 0.2 | 0.446 | 0.18 | 0.438 | 0.512 | 0.762 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0.007 | -0.024 | -0.045 | -0.136 | 0 | -0.219 | -0.256 | -0.381 | 0.007 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 0 | 0.037 | 0.092 | 0.155 | 0.31 | 0.18 | 0.219 | 0.256 | 0.381 | 0.007 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 3.741 | 2.95 | 2.87 | 2.993 | 3.773 | 5.225 | 6.277 | 6.499 | 7.87 | 7.277 | 6.038 | 5.59 | 5.713 | 4.07 | 3.063 | 0 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 182.251 | 152.759 | 92.798 | 46.551 | 26.174 |
Common Stock
| 0.007 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.001 | 0.001 | 0.001 | 0 |
Retained Earnings
| -212.565 | -157.676 | -155.979 | -152.338 | -148.37 | -143.15 | -120.86 | -113.098 | -103.416 | -88.82 | -75.616 | -65.071 | -55.456 | -46.737 | -28.136 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | -0 | -0.002 | -0.011 | -0.035 | -0.095 | -0.358 | -0.581 | -0.604 | -0.521 | -0.123 | -0.018 | 0 | 0 | -0 | -5.562 |
Other Total Stockholders Equity
| 434.835 | 264.057 | 263.577 | 262.088 | 260.903 | 260.102 | 249.93 | 248.035 | 246.252 | 244.48 | 242.939 | 241.747 | 4.61 | 3.554 | 3.152 | 0 |
Total Shareholders Equity
| 222.277 | 106.384 | 107.599 | 109.742 | 112.501 | 116.86 | 128.715 | 134.359 | 142.235 | 155.142 | 167.203 | 176.661 | 101.914 | 49.616 | 21.568 | 20.612 |
Total Equity
| 222.277 | 106.384 | 107.599 | 109.742 | 112.501 | 116.86 | 128.715 | 134.359 | 142.235 | 155.142 | 167.203 | 176.661 | 101.914 | 49.616 | 21.568 | 20.612 |
Total Liabilities & Shareholders Equity
| 226.018 | 109.334 | 110.469 | 112.735 | 116.274 | 122.085 | 134.992 | 140.858 | 150.105 | 162.419 | 173.241 | 182.251 | 107.627 | 53.686 | 24.631 | 20.612 |